RUFY4 and nonpapillary renal cell carcinoma: RGS20, ADA, AICDA, SLC12A5, RUFY4 and CDK5RAP3 were significantly upregulated in ccRCC group, and the RT - qPCR analysis results were consistent (p < 0.05).